相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Relationship between chronological and bone ages and pubertal stage of breasts with bone biomarkers and bone mineral density in adolescents
Cristina Maria Teixeira Fortes et al.
Jornal de Pediatria (2014)
Comparison of Life-Stage-Dependent Internal Dosimetry for Bisphenol A, Ethinyl Estradiol, a Reference Estrogen, and Endogenous Estradiol to Test an Estrogenic Mode of Action in Sprague Dawley Rats
Mona I. Churchwell et al.
TOXICOLOGICAL SCIENCES (2014)
Impact of oral contraceptive on bone metabolism
Florence Tremollieres
BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Effect of two kinds of different combined oral contraceptives use on bone mineral density in adolescent women
Ling Gai et al.
CONTRACEPTION (2012)
Hormonal contraception and bone metabolism: a systematic review
Carmine Nappi et al.
CONTRACEPTION (2012)
Low-dose estrogen combined oral contraceptives may negatively influence physiological bone mineral density acquisition during adolescence
David Cibula et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2012)
Pediatric Osteoporosis: Where Are We Now?
Nina S. Ma et al.
JOURNAL OF PEDIATRICS (2012)
Adolescent Contraception: Review and Guidance for Pediatric Clinicians
Lauren B. Hartman et al.
CURRENT PROBLEMS IN PEDIATRIC AND ADOLESCENT HEALTH CARE (2012)
Cortical bone health shows significant linkage to chromosomes 2p, 3p, and 17q in 10-year-old children
Dana L. Duren et al.
BONE (2011)
Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly
Rene Rizzoli et al.
BONE (2010)
Oral contraceptive use and bone density in adolescent and young adult women
Delia Scholes et al.
CONTRACEPTION (2010)
Low-dose Oral Contraceptives in Adolescents: How Low Can You Go?
H. Agostino et al.
JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY (2010)
Official positions of the International Society for Clinical Densitometry (ISCD) on DXA evaluation in children and adolescents
Maria Luisa Bianchi et al.
PEDIATRIC NEPHROLOGY (2010)
Progesterone and Bone: Actions Promoting Bone Health inWomen
Vanadin Seifert-Klauss et al.
JOURNAL OF OSTEOPOROSIS (2010)
The use of depot-medroxyprogesterone acetate in contraception and its potential impact on skeletal health
Edith R. Guilbert et al.
CONTRACEPTION (2009)
Oral contraception usage in relation to bone mineral density and bone turnover in adolescent girls
M. Lattakova et al.
EUROPEAN JOURNAL OF CONTRACEPTION AND REPRODUCTIVE HEALTH CARE (2009)
Diagnosis and Management of Osteoporosis
Robert W. Lash et al.
PRIMARY CARE (2009)
Estrogen-progestin contraceptive use during adolescence prevents bone mass acquisition:: a 4-year follow-up study
Essi Pikkarainen et al.
CONTRACEPTION (2008)
Fracture risk in very young women using combined oral contraceptives
Peter Vestergaard et al.
CONTRACEPTION (2008)
Effects of depot medroxyprogesterone acetate on bone density and bone metabolism before and after peak bone mass: A case-control study
Jennifer S. Walsh et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2008)
Detrimental effect of oral contraceptives on parameters of bone mass and geometry in a cohort of 248 young women
Manfred Hartard et al.
BONE (2007)
Combined hormonal contraception and bone health: a systematic review
SL Martins et al.
CONTRACEPTION (2006)
Oral contraceptive use in young women is associated with lower bone mineral density than that of controls
HA Shoepe et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Double-blinded randomized controlled trial of estrogen supplementation in adolescent girls who receive depot medroxyprogesterone acetate for contraception
BA Cromer et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Relationship of sex hormones to bone geometric properties and mineral density in early pubertal girls
QJ Wang et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls
BA Cromer et al.
JOURNAL OF ADOLESCENT HEALTH (2004)
Divergent effect of endogenous and exogenous sex steroids on the insulin-like growth factor I response to growth hormone in short normal adolescents
R Coutant et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2004)
Long-term sensitivity of uterus and hypothalamus/pituitary axis to 17β-estradiol is higher than that of bone in rats
RG Erben et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2004)
Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts
V Viereck et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The selective estrogen receptor modulator raloxifene regulates osteoclast and osteoblast activity in vitro
A Taranta et al.
BONE (2002)
Current concepts in pediatric bone disease
MB Leonard et al.
PEDIATRIC CLINICS OF NORTH AMERICA (2002)
Pharmacologic doses of medroxyprogesterone may cause bone loss through glucocorticoid activity: An hypothesis
Y Ishida et al.
OSTEOPOROSIS INTERNATIONAL (2002)
Clinical use of biochemical markers of bone remodeling: Current status and future directions
AC Looker et al.
OSTEOPOROSIS INTERNATIONAL (2000)
分享论文
